Evofem Biosciences, Inc. - 8-K Filing

Evofem Biosciences reports Q3 2026 net income of $0.9 million despite a decline in net sales to $4.6 million. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 13, 2026, 21:59 UTC

Tickers: $EVFM

Read the full article at SEC EDGAR

More Regulatory news

Alset Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:32 UTC
Trump Media & Technology Group Corp. - 4 Filing SEC EDGAR · November 13, 2026, 22:29 UTC
PERPETUA RESOURCES CORP. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:29 UTC
Trump Media & Technology Group Corp. - 4 Filing SEC EDGAR · November 13, 2026, 22:28 UTC
Dragonfly Energy Holdings Corp. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:28 UTC
SYNTEC OPTICS HOLDINGS, INC. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:28 UTC
MACROGENICS INC - 8-K Filing SEC EDGAR · November 13, 2026, 22:28 UTC
Trump Media & Technology Group Corp. - 4 Filing SEC EDGAR · November 13, 2026, 22:28 UTC
Canary XRP ETF - 10-Q Filing SEC EDGAR · November 13, 2026, 22:27 UTC
Eightco Holdings Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:27 UTC